1. Home
  2. PACK vs AURA Comparison

PACK vs AURA Comparison

Compare PACK & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ranpak Holdings Corp

PACK

Ranpak Holdings Corp

HOLD

Current Price

$6.89

Market Cap

653.6M

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$6.66

Market Cap

713.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PACK
AURA
Founded
1972
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
653.6M
713.4M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
PACK
AURA
Price
$6.89
$6.66
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$6.50
$20.00
AVG Volume (30 Days)
574.7K
717.0K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$395,000,000.00
N/A
Revenue This Year
$9.29
N/A
Revenue Next Year
$8.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.08
N/A
52 Week Low
$3.22
$4.73
52 Week High
$7.81
$9.54

Technical Indicators

Market Signals
Indicator
PACK
AURA
Relative Strength Index (RSI) 52.25 47.86
Support Level $6.59 $6.34
Resistance Level $7.16 $7.04
Average True Range (ATR) 0.35 0.55
MACD -0.09 0.02
Stochastic Oscillator 46.85 23.13

Price Performance

Historical Comparison
PACK
AURA

About PACK Ranpak Holdings Corp

Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: